Concepedia

Publication | Open Access

One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis

DOIFull Paper Access

58

Citations

15

References

2022

Year

Alexander Tanner, Fadi Haddad, Julia Fajardo-Sanchez, Ethan Nguyen, Kai Xin Thong, Sarah Ah-Moye, Nicole Perl, Mohammed Abu-Bakra, Avinash Kulkarni, Sameer Trikha,
British Journal of Ophthalmology

Abstract

The PreserFlo MicroShunt with MMC 0.4 mg/mL showed an overall success rate of 68.3% at 1 year, and led to significant IOP and medication reduction with a low rate of adverse effects.

References

YearCitations

Page 1